Synthesis and biological evaluation of novel fluconazole analogues bearing 1,3,4-oxadiazole moiety as potent antifungal agents

Arch Pharm Res. 2015 Apr;38(4):470-9. doi: 10.1007/s12272-014-0378-5. Epub 2014 May 17.

Abstract

A novel series of fluconazole based mimics incorporating 1,3,4-oxadiazole moiety were designed and synthesized. All the title compounds were characterized by (1)H-NMR, (13)C-NMR, and Q-TOF-MS. Preliminary results revealed that most of analogues exhibited significant antifungal activity against seven pathogenic fungi. Compounds 9g and 9k (MIC80 ≤ 0.125 μg/mL, respectively) were found more potent than the positive controls itraconazole and fluconazole as broad-spectrum antifungal agents. The observed docking results showed that the 1,3,4-oxadiazole moiety enhanced the affinity binding to the cytochrome P450 14α-demethylase (CYP51).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / chemical synthesis*
  • Antifungal Agents / pharmacology
  • Binding Sites
  • Candida albicans / drug effects
  • Drug Evaluation, Preclinical / methods
  • Fluconazole / analogs & derivatives*
  • Fluconazole / chemical synthesis*
  • Fluconazole / pharmacology
  • Humans
  • Microbial Sensitivity Tests / methods
  • Oxadiazoles / chemical synthesis*
  • Oxadiazoles / pharmacology
  • Structure-Activity Relationship

Substances

  • Antifungal Agents
  • Oxadiazoles
  • 1,3,4-oxadiazole
  • Fluconazole